Intuitive Surgical's Strong Demand and Analyst Optimism Fuel Upside Potential
Intuitive Surgical stock has fallen 30% from early 2025 highs, but analysts expect the surgical robotics leader to recover due to strong demand for its da Vinci system. The company reported 12% year-over-year growth in installed systems and 17% growth in surgeries performed, with a 75% reliance on recurring revenue. Analysts' $570 price target suggests 30%+ upside potential.
Intuitive Surgical's stock has endured a 30% dip from its early 2025 highs, despite the robust demand for its da Vinci system. Analysts remain optimistic about the surgical robotics leader's prospects, supported by significant year-over-year growth rates for both installed systems (12%) and surgeries performed (17%) . A substantial 75% of the company's revenue comes from recurring sales of instruments, accessories, and services, a key factor in its resilience.
Analysts have set an average price target of $570 per share for Intuitive Surgical, indicating 30%+ upside potential for the stock. This optimism is underpinned by historical precedent: similar downturns in the stock have been followed by strong recoveries . As Intuitive Surgical continues to drive growth in its installed systems and procedure volumes, its appeal to investors is expected to endure.
Overall, the combination of resilient demand for its da Vinci system, a robust recurring revenue model, and a strong analyst consensus on its valuation should provide a firm foundation for Intuitive Surgical to recover and continue growing in the future.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis